Principal owner of Diamyd Medical transfers subscription rights to endowment insurance
Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announed today that its principal owner, and also the CEO of the Company, Anders Essen-Möller, who will subscribe for his full share of the Company’s ongoing share issue corresponding to approximately 21 percent or MSEK 4.6 of the total share issue of MSEK 22.1, has transferred 3,613,455 of his Series B subscription rights in Diamyd Medical to an endowment insurance. Accordingly, the corresponding new Series B shares, 1,204,485, will be held in an endowment insurance. “There are certain tax advantages to holding securities in